As a leader in pharmaceutical technology, CD Formulation is dedicated to the advanced research and development of transdermal formulation technology. Our expertise lies in providing custom R&D services for researchers, focusing on developing safe and efficient transdermal drug delivery systems. We employ cutting-edge techniques to ensure precise, reliable evaluation and formulation processes.
Biological evaluation is crucial for verifying the safety and efficacy of transdermal formulations. At CD Formulation, our interdisciplinary team of experienced scientists and pharmacologists utilizes state-of-the-art biotechnology, cell culture methods, and molecular biology to conduct comprehensive, multi-level assessments. Our services include skin permeability testing, irritation evaluation, and pharmacokinetic and pharmacodynamic studies, ensuring accurate data to support your R&D efforts.
In vivo animal experiments, we have observed that the accumulation of drugs in the skin is closely related to the formulation and mode of administration of the preparation. By optimizing the formulation, we can control skin drug levels, enhancing efficacy and minimizing adverse effects.
To evaluate the irritation and sensitization of transdermal preparations to the skin to ensure safety. Animal experiments (such as a guinea pig sensitization test) or human experiments (such as a skin patch test) are usually used to detect whether the preparation will cause skin irritation or allergic reaction.
Adhesion testing of transdermal products is an important step in evaluating the adhesion performance of transdermal products (such as transdermal patches) on the skin. This test ensures that the patch can effectively adhere to the skin during the intended use and avoid falling off during daily activities.
To understand the absorption, distribution, metabolism, and excretion of transdermal preparations in vivo through experimental animals or human trials. The plasma drug concentration-time curve is usually used to calculate the drug's bioavailability, maximum concentration (Cmax), time to reach maximum concentration (Tmax), and drug half-life.
Evaluate the therapeutic effect and mechanism of action of transdermal preparations. Usually verify the efficacy and duration of action of the preparation through animal models.
Fig.1 Schematic diagram of in vitro permeation. (Francesco Cilurzo, et al. 2018)
Technology: Technology for In vitro permeation
Journal: European Journal of Pharmaceutical Sciences
IF: 3.2
Published: 2018
Results: Transdermal patches and medicated plasters are designed to sustain efficacious systemic or loco-regional drug concentrations, respectively. In both cases, drug skin permeation is a critical attribute from the early stage of the pharmaceutical development. In 2014, the EMA introduced the "Guideline on the quality of transdermal patches", in which the importance of equivalence of drug fluxes in vitro skin permeation study was particularly emphasized to generic or abridged applications for the marketing authorization or manage dossier variations during the product cycle life. Moving from experimental data, this work provides information on the setup of such studies and the statistical evaluation of obtained fluxes.
CD Formulation has a professional technical team and perfect testing equipment, to provide quality biological evaluation services for transdermal formulations. If you have any needs, please feel free to contact us and our colleagues will contact you within three working days.
References